Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial

OBJECTIVES: The aim of this study is to assess whether restaging transurethral resection (ReTUR) could be safely replaced with urine cytology (UC) and in-office fiexible cystoscopy in selected T1 non-muscle-invasive bladder cancer (NMIBC). MATERIALS AND METHODS: This is an ongoing prospective multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Contieri, Roberto, Lughezzani, Giovanni, Buffi, Nicolò Maria, Taverna, Gianluigi, Giacobbe, Alessandro, Micheli, Emanuele, Barra, Sabato, Colombo, Piergiuseppe, Vanni, Elena, Guazzoni, Giorgio, Lazzeri, Massimo, Hurle, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157494/
https://www.ncbi.nlm.nih.gov/pubmed/35664755
http://dx.doi.org/10.3389/fonc.2022.879399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157494/
https://www.ncbi.nlm.nih.gov/pubmed/35664755
http://dx.doi.org/10.3389/fonc.2022.879399

Ejemplares similares